Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Holmes

Showing results (391-400 of 483) with videos related to

Pageof 49
Sort By:
Journal of the American College of Cardiology|March 19, 2013
Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillationOluseun Alli, Shepal Doshi, Saibal Kar, et al.
Circulation|July 2, 2003
Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosisDavid Simper, Shaohua Wang, Arjun Deb, et al.
The American Journal of Cardiology|February 13, 2007
Frequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-upGurpreet Sandhu, Brendan Doyle, Ripudamanjit Singh, et al.
Journal of the American College of Cardiology|March 3, 2012
The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudyJuan F Viles-Gonzalez, Saibal Kar, Pamela Douglas, et al.
Circulation|January 18, 2013
Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) TrialVivek Y Reddy, Shephal K Doshi, Horst Sievert, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 14, 2002
Primary care education: measuring instruction to improve qualityPaul A James, Judith A Shipengrover, Jesse Crosson, et al.
Lab on a Chip|October 1, 2009
Leukocyte analysis and differentiation using high speed microfluidic single cell impedance cytometryDavid Holmes, David Pettigrew, Christian H Reccius, et al.
Annals of Work Exposures and Health|July 30, 2021
Contamination of Air and Surfaces in Workplaces with SARS-CoV-2 Virus: A Systematic ReviewJohn W Cherrie, Mark P C Cherrie, Alice Smith, et al.
Heart (British Cardiac Society)|November 24, 2020
Comorbidity burden in patients undergoing left atrial appendage closureShubrandu Sanjoy, Yun-Hee Choi, David Holmes, et al.
JAMIA Open|March 13, 2024
Evaluating and improving the usability of a mHealth platform to assess postoperative dental painAna M Ibarra-Noriega, Alfa Yansane, Joanna Mullins, et al.
Pageof 49

Showing results (391-400 of 483) with videos related to

Sort By:
Pageof 49
Journal of the American College of Cardiology|March 19, 2013
Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillationOluseun Alli, Shepal Doshi, Saibal Kar, et al.
Circulation|July 2, 2003
Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosisDavid Simper, Shaohua Wang, Arjun Deb, et al.
The American Journal of Cardiology|February 13, 2007
Frequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-upGurpreet Sandhu, Brendan Doyle, Ripudamanjit Singh, et al.
Journal of the American College of Cardiology|March 3, 2012
The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudyJuan F Viles-Gonzalez, Saibal Kar, Pamela Douglas, et al.
Circulation|January 18, 2013
Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) TrialVivek Y Reddy, Shephal K Doshi, Horst Sievert, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 14, 2002
Primary care education: measuring instruction to improve qualityPaul A James, Judith A Shipengrover, Jesse Crosson, et al.
Lab on a Chip|October 1, 2009
Leukocyte analysis and differentiation using high speed microfluidic single cell impedance cytometryDavid Holmes, David Pettigrew, Christian H Reccius, et al.
Annals of Work Exposures and Health|July 30, 2021
Contamination of Air and Surfaces in Workplaces with SARS-CoV-2 Virus: A Systematic ReviewJohn W Cherrie, Mark P C Cherrie, Alice Smith, et al.
Heart (British Cardiac Society)|November 24, 2020
Comorbidity burden in patients undergoing left atrial appendage closureShubrandu Sanjoy, Yun-Hee Choi, David Holmes, et al.
JAMIA Open|March 13, 2024
Evaluating and improving the usability of a mHealth platform to assess postoperative dental painAna M Ibarra-Noriega, Alfa Yansane, Joanna Mullins, et al.
Pageof 49